# K091760: Dermaport Ported Vascular Access System (Pvas)

- Pathway: 510(k) (Special)
- Applicant: Dermaport, Inc.
- Decided: Jul 20, 2009 after 34 days
- Product code: MSD (Catheter, Hemodialysis, Implanted)
- Device class: 2
- Regulation: 21 CFR 876.5540
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K013160 (2002). 10 ancestors in all.
No later device cites it as a predicate yet.
0 of 11 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K071202: Dermaport Percutaneous Vascular Access System (Pvas), Dermaport, Inc. (2007) Summary page 1.

## Indications for use
The DermaPort Ported Vascular Access System (PVASTM) is indicated for long-term (greater than 30 days) vascular access for hemodialysis and apheresis. The system is inserted percutaneously and typically placed in the internal jugular vein of an adult patient. The subclavian vein is an alternate catheter insertion site.

Source page: https://510kreport.com/device/K091760
Methodology: https://510kreport.com/methodology